/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
BioVie Inc. (the Company or we or our ) is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease. Neurodegenerative Disease Program The Company acquired the biopharmaceutical assets of NeurMedix, Inc. ( NeurMedix ) a privately held clinical-stage pharmaceutical company and a related party in Jun…
$1.61
$0.17 (-9.55%)
EOD Sep 18, 2026
ROIC dropped from -62.08% to -119.67%, capital efficiency is deteriorating.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$22M
▼ -25.8% YoY
Op. Margin
—
ROIC
-119.67%
▼ -57.6pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$19M
Net Debt
-$9M
Net Cash Position
Cash & Equiv.
$9M
Continue Research
SourceComputed from the 10-Q filed 13 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 14 Aug 2026. How this is calculated.
Price from market data, last close as of 18 Sept 2026. Fiscal year ends Jun. Sector medians are approximate S&P 500 benchmarks and update periodically.